| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.6M | +3.1% | +57.4% |
| Cost of Revenue | $1.9M | +5.8% | +89.8% |
| Gross Profit | $9.7M | +2.6% | +52.2% |
| R&D Expense | $5.2M | +31.9% | +22.7% |
| SG&A Expense | $6.7M | +17.7% | +40.9% |
| Operating Income | -$9.0M | -22.9% | -3.1% |
| Pre-tax Income | -$10.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $22.7M | -14.4% | +101.0% |
| Accounts Receivable | $5.0M | -10.2% | +1.8% |
| Inventory | $3.3M | -13.9% | -18.1% |
| Current Assets | $33.3M | -12.5% | +40.0% |
| Total Assets | $36.5M | -11.7% | +32.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$15.5M | — | — |
| Capital Expenditures | $877K | — | — |
| Investing Cash Flow | -$797K | — | — |
| Financing Cash Flow | $30.5M | — | — |
| Free Cash Flow | -$16.4M | — | — |
| -30.3% |
| -349.9% |
| Income Tax | $5K | +266.7% | +266.7% |
| Net Income | -$10.8M | -30.4% | -350.6% |
| EPS (Basic) | -$0.96 | -255.6% | -700.0% |
| EPS (Diluted) | -$0.96 | -255.6% | -700.0% |
| $10.9M |
| +17.0% |
| +10.0% |
| Long-term Debt | $32.8M | +1.5% | +51.1% |
| Total Liabilities | $63.2M | +4.0% | +31.9% |
| Stockholders' Equity | -$26.7M | -37.6% | -30.8% |